FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer
The US Food and Drug Administration has approved a treatment for pancreatic cancer that, in clinical trials, nearly doubled the overall survival time for patients. The drug, daraxonrasib, sold under…
